Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45747, first published .
Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study

Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study

Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study

Journals

  1. Huang K. The Need for a Bleed Type–Specific Annual Bleeding Rate in Hemophilia Studies. JMIR Public Health and Surveillance 2024;10:e51372 View
  2. Wang L, Liu S, Jiang S, Li C, Lu L, Fang Y, Li S. Authors’ Reply: “The Need for a Bleed Type–Specific Annual Bleeding Rate in Hemophilia Studies”. JMIR Public Health and Surveillance 2024;10:e54756 View
  3. Nouwens S, Marceta S, Bui M, van Dijk D, Groothuis-Oudshoorn C, Veldwijk J, van Til J, de Bekker-Grob E. The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review. PharmacoEconomics 2025 View